申请人:ENVOY THERAPEUTICS INC
公开号:WO2014014962A1
公开(公告)日:2014-01-23
The present invention provides compounds of the formula: (I) that are 5HT3 receptor antagonists and are therefore useful for the treatment of diseases treatable by inhibition of 5HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.